Efficacy of local–regional radiotherapy in de novo metastatic nasopharyngeal carcinoma patients receiving chemo-immunotherapy: A multicenter, propensity score matching study
- 19 December 2024
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 203, 110687
Abstract
No abstract availableKeywords
Funding Information
- Basic and Applied Basic Research Foundation of Guangdong Province (2021B1515120013)
- Guangzhou Municipal Science and Technology Program key projects
- National Natural Science Foundation of China (62,220,106,006, 82203755)
This publication has 36 references indexed in Scilit:
- Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: A multicenter phase 3 trial (RATIONALE-309)Cancer Cell, 2023
- Association of Plasma Epstein-Barr Virus DNA With Outcomes for Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma Receiving Anti–Programmed Cell Death 1 ImmunotherapyJAMA Network Open, 2022
- Identifying the optimal candidates for locoregional radiation therapy in patients with de novo metastatic nasopharyngeal carcinomaHead & Neck, 2021
- Efficacy and Safety of Locoregional Radiotherapy With Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal CarcinomaJAMA Oncology, 2020
- Evolution of Metastases in Space and Time under Immune SelectionCell, 2018
- Combined Radiotherapy and Anti–PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non–Small Cell Lung CancerJournal of Thoracic Oncology, 2017
- Tumor response to neoadjuvant chemotherapy predicts long‐term survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: A secondary analysis of a randomized phase 3 clinical trialCancer, 2016
- The Prognostic Value of Plasma Epstein-Barr Viral DNA and Tumor Response to Neoadjuvant Chemotherapy in Advanced-Stage Nasopharyngeal CarcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2015
- Co-expression of PD-1 and PD-L1 predicts poor outcome in nasopharyngeal carcinomaMedical Oncology, 2015
- Lung metastasis alone in nasopharyngeal carcinoma: A relatively favorable prognostic groupCancer, 2004